摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-methoxyseselin | 199393-47-0

中文名称
——
中文别名
——
英文名称
3-methoxyseselin
英文别名
3-Methoxy-8,8-dimethylpyrano[2,3-f]chromen-2-one
3-methoxyseselin化学式
CAS
199393-47-0
化学式
C15H14O4
mdl
——
分子量
258.274
InChiKey
OXCFIFIJGCLQPN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    19
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.27
  • 拓扑面积:
    44.8
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (1S)-(-)-莰烷酰氯3-methoxyseselin吡啶 、 potassium dioxotetrahydroxoosmate(VI) 、 hydroquinidine-2,5-diphenyl-4,6-pyrimidinediyl diether 、 potassium carbonate 、 potassium hexacyanoferrate(III) 作用下, 生成 3-methoxy-3',4'-di-O-(-)-camphanoyl-(+)-cis-khellactone
    参考文献:
    名称:
    Anti-AIDS agents-XXVIII.1 Synthesis and Anti-HIV activity of methoxy substituted 3′,4′-Di-O-(−)-camphanoyl-(+)-cis-khellactone (DCK) analogues
    摘要:
    Four isomeric methoxy substituted DCK analogues (3-6) were asymmetrically synthesized from different starting materials. 5-Methoxy-3',4'-di-O-(-)-camphanoyl-(+)-cis-khellactone (5) exhibited extremely potent anti-HIV activity against HIV-1 replication in H9 lymphocyte cells with EC50 and therapeutic index values of 0.00038 mu M and >402,632, respectively, which are better than those of DCK and AZT in this assay. (C) 1997 Elsevier Science Ltd.
    DOI:
    10.1016/s0960-894x(97)10050-6
  • 作为产物:
    描述:
    参考文献:
    名称:
    Anti-AIDS agents-XXVIII.1 Synthesis and Anti-HIV activity of methoxy substituted 3′,4′-Di-O-(−)-camphanoyl-(+)-cis-khellactone (DCK) analogues
    摘要:
    Four isomeric methoxy substituted DCK analogues (3-6) were asymmetrically synthesized from different starting materials. 5-Methoxy-3',4'-di-O-(-)-camphanoyl-(+)-cis-khellactone (5) exhibited extremely potent anti-HIV activity against HIV-1 replication in H9 lymphocyte cells with EC50 and therapeutic index values of 0.00038 mu M and >402,632, respectively, which are better than those of DCK and AZT in this assay. (C) 1997 Elsevier Science Ltd.
    DOI:
    10.1016/s0960-894x(97)10050-6
点击查看最新优质反应信息

文献信息

  • Anti-AIDS Agents. 37. Synthesis and Structure−Activity Relationships of (3‘<i>R</i>,4‘<i>R</i>)-(+)-<i>cis</i>-Khellactone Derivatives as Novel Potent Anti-HIV Agents
    作者:Lan Xie、Yasuo Takeuchi、L. Mark Cosentino、Kuo-Hsiung Lee
    DOI:10.1021/jm9900624
    日期:1999.7.1
    (+)-cis-khellactone derivatives as novel anti-HIV agents, 24 monosubstituted 3', 4'-di-O-(S)-camphanoyl-(+)-cis-khellactone (DCK) derivatives were synthesized asymmetrically. These compounds included 4 isomeric monomethoxy analogues (3-6), 4 isomeric monomethyl analogues (7-10), 4 4-alkyl/aryl-substituted analogues (11-14), and 12 4-methyl-(+)-cis-khellactone derivatives (15-26) with varying 3', 4'-substituents
    为了探索作为新型抗HIV药物的(+)-顺式-khellactone衍生物的结构要求,使用24个单取代的3',4'-di-O-(S)-樟脑酰基-(+)-顺式-khellactone(DCK)衍生物不对称合成。这些化合物包括4个异构的单甲氧基类似物(3-6),4个异构的单甲基类似物(7-10),4个4-烷基/芳基取代的类似物(11-14)和12个4-甲基-(+)-顺式具有3',4'取代基的khellactone衍生物(15-26)。这些(+)-顺式-khellactone衍生物被筛选针对急性感染的H9淋巴细胞中的HIV-1复制。结果表明,(3'R,4'R)-(+)-顺式-khellactone骨架,3'-和4'-位置的两个(S)-(-)-樟脑酰基和甲基除6-位以外,香豆素环上的α是抗HIV活性的最佳结构部分。3-甲基-(7),4-甲基-(8)和5-甲基-(9)3',4'-二-O-(S)-樟脑酰基-(3'R,4'R)-
  • Anti-AIDS agents-XXVIII.1 Synthesis and Anti-HIV activity of methoxy substituted 3′,4′-Di-O-(−)-camphanoyl-(+)-cis-khellactone (DCK) analogues
    作者:Yasuo Takeuchi、Lan Xie、L.Mark Cosentino、Kuo-Hsiung Lee
    DOI:10.1016/s0960-894x(97)10050-6
    日期:1997.10
    Four isomeric methoxy substituted DCK analogues (3-6) were asymmetrically synthesized from different starting materials. 5-Methoxy-3',4'-di-O-(-)-camphanoyl-(+)-cis-khellactone (5) exhibited extremely potent anti-HIV activity against HIV-1 replication in H9 lymphocyte cells with EC50 and therapeutic index values of 0.00038 mu M and >402,632, respectively, which are better than those of DCK and AZT in this assay. (C) 1997 Elsevier Science Ltd.
查看更多